There have been a number of developments over the years in the biocides industry from regulatory clampdowns through to consolidations and divestments. This year we witnessed a record investment with the acquisition of Lonza Specialty Ingredients for US$4.7 billion a 13x EBITDA multiplier.
This webinar aims to provide a high-level overview of developments affecting the biocides industry, from regulations and the impact of COVID-19 to green alternatives and M&A activities, including the anticipated divestment of IFF’s anti-microbial business.
